Rate My Professor Geoff Baldwin

Professor Geoff Baldwin holds the position of Professor of Synthetic and Molecular Biology in the Department of Life Sciences within the Faculty of Natural Sciences at Imperial College London. He earned his PhD in Biochemistry, with research on DNA-protein interactions, and joined Imperial College in 2000 as a BBSRC David Phillips Fellow. Throughout his career, Baldwin has worked at the interface of physical sciences, life sciences, and engineering. He is a Fellow of the Royal Society of Biology, elected in 2013, and a Fellow of the Royal Society of Chemistry, elected in 2014. Baldwin previously served as Reader in Biochemistry before his promotion to Professor.

Baldwin is Co-Director of the Imperial College Centre for Synthetic Biology and Director of the EPSRC Centre for Doctoral Training in BioDesign Engineering, a collaborative program with University College London and the University of Manchester. His research focuses on synthetic biology, including the development of standardized genetic parts, genetic circuits, and advanced DNA assembly techniques such as the BASIC method for idempotent cloning of complex synthetic genetic systems. Key publications include co-editing the book Synthetic Biology: A Primer (revised edition, Imperial College Press, 2015), which covers foundational concepts, engineering approaches, minimal cells, and applications; 'A New Biopart Assembly Standard for Idempotent Cloning Provides Accurate Design of Complex Synthetic Genetic Systems' (ACS Synthetic Biology, 2015); and 'Engineering Control of Bacterial Cellulose Production Using a Genetic Toolkit in a Synthetic Biology Framework' (PNAS, 2016). He has led significant funding initiatives, including the UKRI Infrastructure for Synthetic and Precision Engineering Biology award of over £12 million to Imperial College London. Baldwin has advised Imperial College's successful iGEM teams, developed training pipelines for synthetic biologists, and contributed to parliamentary submissions on synthetic biology. He has also participated in international symposia, such as the UK-Korea symposium on engineering biology, and supported spin-outs commercializing synthetic biology technologies.